Back
Inventiva SA Vs. Innate Pharma SA Industry Stock Comparison
Sell
33
IVA
Inventiva SA
Last Price:
2.11
Seasonality Move:
5.9%
Sell
16
IPHA
Innate Pharma SA
Last Price:
2.16
Seasonality Move:
-22.97%
Sell
33
Inventiva SA (IVA)
is a Sell
Is Inventiva SA a Buy, Sell or Hold?
- The current Inventiva SA [IVA] share price is $2.05. The Score for IVA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- IVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $2.25. The Score for IPHA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IVA Stock Price Chart
What is Inventiva SA's stock price today?
-
The Inventiva SA share price today is $2.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVA is experiencing selling pressure, which indicates risk of future bearish movement.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.
IVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 31.36 | Sell |
Chaikin Money Flow: | -18065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.18 - 2.38) | Sell |
Bollinger Bands (100): | (2.23 - 3.33) | Sell |
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.21 - 2.33) | Sell |
Bollinger Bands (100): | (2.08 - 2.6) | Sell |
IVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.18 | Sell |
20-day SMA: | 2.26 | Sell |
50-day SMA: | 2.31 | Sell |
200-day SMA: | 3.33 | Sell |
8-day EMA: | 2.16 | Sell |
20-day EMA: | 2.23 | Sell |
50-day EMA: | 2.39 | Sell |
200-day EMA: | 3.12 | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Sell |
20-day SMA: | 2.27 | Sell |
50-day SMA: | 2.23 | Buy |
200-day SMA: | 2.46 | Sell |
8-day EMA: | 2.25 | Sell |
20-day EMA: | 2.26 | Sell |
50-day EMA: | 2.26 | Sell |
200-day EMA: | 2.43 | Sell |
Inventiva SA Earnings Growth & IVA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.11 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Inventiva SA Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innate Pharma SA Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |